Proven track record in modified-release dosage forms
Modified-release dosage forms can enhance the safety, efficacy, reliability, and convenience of drug therapy by controlling the rate and duration of drug release. Technology transfers for modified-release oral solid dose (OSD) drugs are particularly challenging. CDMOs with experience in these technologies are more likely to succeed in transferring relevant processes and knowledge without compromising the safety and quality of their clients’ products.
Bora’s experienced team can handle routine to complex manufacturing processes for your extended/delayed-release drugs. In addition, we have extensive experience in organic solvent handling, Wurster coating, multi-particulate encapsulation and extrusion-spheronization.
Looking for a trusted partner to bring your breakthrough drug successfully to the market?
Our team is here to discuss how you can gain competitive advantage by gearing Bora’s rich and diverse manufacturing and packaging expertise towards your commercial success.